The table below shows ENANTA PHARMACEUTICALS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q4 2025
Q4 2024
Q4 2023
Q4 2022
Q4 2021
Q4 2020
Operating cash flow
-$11.70M
-$16.80M
-$24.99M
-$35.64M
-$13.27M
-$14.89M
Capital expenditure
$143.00K
$8.74M
$787.00K
$3.16M
$363.00K
$188.00K
Investing cash flow
-$47.30M
$68.90M
-$13.12M
$33.57M
$45.50M
-$17.45M
Dividends paid
-
-
-
-
ENTA operating cash flow (10-K history)
ENANTA PHARMACEUTICALS INC reported operating cash flow of -$19.27M for fiscal year 2025. That is up 75.5% from -$78.76M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $35.81M (FY 2016) to -$19.27M. Figures come from the company's audited annual reports as filed with the SEC.